Clinical Trials · NCT06492135
A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 30
- Start date
- Aug 2024
- Locations
- 1 site, China
- Primary endpoint
- AUC0-168 (area under the concentration-time curve of survodutide in plasma over the time interval from 0 to 168h)